Given the IHC loss of all MMR proteins and the somatic absence of c.1799T>A, p.(V600E) variant in the BRAF gene, further in-depth investigations were performed on the tumor tissue with the aim to elucidate the underlying genetic and molecular alterations contributing to the observed phenotypic characteristics. This evidence concerns the gene BRAF and neoplasm.